Estrogen receptor α signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2386-2393

  Lélu, Karine ^a,b,c   Laffont, Sophie ^a,b,c   Delpy, Laurent ^d   Paulet, Pierre Emmanuel ^a,b,c   Périnat, Therese ^e   Tschanz, Stefan A ^f   Pelletier, Lucette ^a,b,c   Engelhardt, Britta ^e   Guéry, Jean Charles ^a,b,c,g  

^a INSERM   (France)

^b CNRS   (France)

^c France   (France)

^d UNIVERSITY OF LIMOGES   (France)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC CELL; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ANIMALS; BLOTTING, SOUTHERN; CELL DIFFERENTIATION; CELL SEPARATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS;

EID: 80052688903     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101578     Document Type: Article

References (47)

1. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85: 299-302. (Pubitemid 26160700)
2. Abramsky, O. 1994. Pregnancy and multiple sclerosis. Ann. Neurol. 36(Suppl): S38-S41. (Pubitemid 24220841)
3. Korn-Lubetzki, I., E. Kahana, G. Cooper, and O. Abramsky. 1984. Activity of multiple sclerosis during pregnancy and puerperium. Ann. Neurol. 16: 229-231. (Pubitemid 14062670)
4. Confavreux, C., M. Hutchinson, M. M. Hours, P. Cortinovis-Tourniaire, and T. Moreau; Pregnancy in Multiple Sclerosis Group. 1998. Rate of pregnancy-related relapse in multiple sclerosis. N. Engl. J. Med. 339: 285-291. (Pubitemid 28366416)
5. Jansson, L., T. Olsson, and R. Holmdahl. 1994. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol. 53: 203-207.
6. Bebo, B. F., Jr., A. Fyfe-Johnson, K. Adlard, A. G. Beam, A. A. Vandenbark, and H. Offner. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166: 2080-2089. (Pubitemid 32114698)
7. Sicotte, N. L., S. M. Liva, R. Klutch, P. Pfeiffer, S. Bouvier, S. Odesa, T. C. Wu, and R. R. Voskuhl. 2002. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52: 421-428.
8. Soldan, S. S., A. I. Alvarez Retuerto, N. L. Sicotte, and R. R. Voskuhl. 2003. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 171: 6267-6274. (Pubitemid 37467250)
9. Polanczyk, M., A. Zamora, S. Subramanian, A. Matejuk, D. L. Hess, E. P. Blankenhorn, C. Teuscher, A. A. Vandenbark, and H. Offner. 2003. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am. J. Pathol. 163: 1599-1605. (Pubitemid 37175106)
10. Liu, H. B., K. K. Loo, K. Palaszynski, J. Ashouri, D. B. Lubahn, and R. R. Voskuhl. 2003. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol. 171: 6936-6940. (Pubitemid 37532130)
11. Garidou, L., S. Laffont, V. Douin-Echinard, C. Coureau, A. Krust, P. Chambon, and J. C. Guéry. 2004. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 173: 2435-2442. (Pubitemid 39063100)
12. Ito, A., B. F. Bebo, Jr., A. Matejuk, A. Zamora, M. Silverman, A. Fyfe-Johnson, and H. Offner. 2001. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167: 542-552. (Pubitemid 32567822)
13. Wang, C., B. Dehghani, Y. Li, L. J. Kaler, A. A. Vandenbark, and H. Offner. 2009. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 126: 329-335.
14. Polanczyk, M. J., B. D. Carson, S. Subramanian, M. Afentoulis, A. A. Vandenbark, S. F. Ziegler, and H. Offner. 2004. Cutting edge: estrogen drives expansion of the CD4+CD25+ regulatory T cell compartment. J. Immunol. 173: 2227-2230. (Pubitemid 39063075)
15. Liu, H. Y., A. C. Buenafe, A. Matejuk, A. Ito, A. Zamora, J. Dwyer, A. A. Vandenbark, and H. Offner. 2002. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70: 238-248.
16. Polanczyk, M. J., R. E. Jones, S. Subramanian, M. Afentoulis, C. Rich, M. Zakroczymski, P. Cooke, A. A. Vandenbark, and H. Offner. 2004. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol. 165: 2069-2077. (Pubitemid 39578384)
17. Dupont, S., A. Krust, A. Gansmuller, A. Dierich, P. Chambon, and M. Mark. 2000. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 127: 4277-4291.
18. Koni, P. A., S. K. Joshi, U. A. Temann, D. Olson, L. Burkly, and R. A. Flavell. 2001. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J. Exp. Med. 193: 741-754.
19. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Fö rster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277. (Pubitemid 29523965)
20. Toutain, C. E., C. Filipe, A. Billon, C. Fontaine, L. Brouchet, J. C. Guéry, P. Gourdy, J. F. Arnal, and F. Lenfant. 2009. Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler. Thromb. Vasc. Biol. 29: 1543-1550.
21. Billon-Galés, A., C. Fontaine, V. Douin-Echinard, L. Delpy, H. Berges, B. Calippe, F. Lenfant, H. Laurell, J. C. Guéry, P. Gourdy, and J. F. Arnal. 2009. Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 120: 2567-2576.
22. Calippe, B., V. Douin-Echinard, L. Delpy, M. Laffargue, K. Lélu, A. Krust, B. Pipy, F. Bayard, J. F. Arnal, J. C. Guéry, and P. Gourdy. 2010. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J. Immunol. 185: 1169-1176.
23. Caton, M. L., M. R. Smith-Raska, and B. Reizis. 2007. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204: 1653-1664. (Pubitemid 47048031)
24. Lee, P. P., D. R. Fitzpatrick, C. Beard, H. K. Jessup, S. Lehar, K. W. Makar, M. Pérez-Melgosa, M. T. Sweetser, M. S. Schlissel, S. Nguyen, et al. 2001. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15: 763-774. (Pubitemid 34008504)
25. Foucras, G., J. D. Coudert, C. Coureau, and J. C. Guéry. 2000. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation. J. Immunol. 165: 4994-5003.
26. Foucras, G., A. Gallard, C. Coureau, J. M. Kanellopoulos, and J.-C. Guéry. 2002. Chronic soluble antigen sensitization primes a unique memory/effector T cell repertoire associated with th2 phenotype acquisition in vivo. J. Immunol. 168: 179-187. (Pubitemid 34014117)
27. Tschanz, S. A., P. H. Burri, and E. R. Weibel. 2011. A simple tool for stereological assessment of digital images: the STEPanizer. J. Microsc. 243: 47-59.
28. Pendaries, C., B. Darblade, P. Rochaix, A. Krust, P. Chambon, K. S. Korach, F. Bayard, and J. F. Arnal. 2002. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc. Natl. Acad. Sci. USA 99: 2205-2210.
29. Heppner, F. L., M. Greter, D. Marino, J. Falsig, G. Raivich, N. Hövelmeyer, A. Waisman, T. Rülicke, M. Prinz, J. Priller, et al. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11: 146-152. (Pubitemid 40321349)
30. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334. (Pubitemid 40460562)
31. Papenfuss, T. L., N. D. Powell, M. A. McClain, A. Bedarf, A. Singh, I. E. Gienapp, T. Shawler, and C. C. Whitacre. 2011. Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity. J. Immunol. 186: 3346-3355.
32. Giraud, S. N., C. M. Caron, D. Pham-Dinh, P. Kitabgi, and A. B. Nicot. 2010. Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes. Proc. Natl. Acad. Sci. USA 107: 8416-8421.
33. Spence, R. D., M. E. Hamby, E. Umeda, N. Itoh, S. Du, A. J. Wisdom, Y. Cao, G. Bondar, J. Lam, Y. Ao, et al. 2011. Neuroprotection mediated through estrogen receptor-{alpha} in astrocytes. Proc. Natl. Acad. Sci. U S A. 108: 8867-8872.
34. Tiwari-Woodruff, S., L. B. Morales, R. Lee, and R. R. Voskuhl. 2007. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER) alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. USA 104: 14813-14818. (Pubitemid 350003225)
35. Saijo, K., J. G. Collier, A. C. Li, J. A. Katzenellenbogen, and C. K. Glass. 2011. An ADIOL-ERb-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 145: 584-595.
36. Lélu, K., L. Delpy, V. Robert, E. Foulon, S. Laffont, L. Pelletier, B. Engelhardt, and J. C. Guéry. 2010. Endogenous estrogens, through estrogen receptor α, constrain autoimmune inflammation in female mice by limiting CD4+ T-cell homing into the CNS. Eur. J. Immunol. 40: 3489-3498.
37. Losel, R. M., E. Falkenstein, M. Feuring, A. Schultz, H. C. Tillmann, K. Rossol-Haseroth, and M. Wehling. 2003. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83: 965-1016. (Pubitemid 36828929)
38. Levin, E. R. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19: 1951-1959. (Pubitemid 41124194)
39. Prossnitz, E. R., J. B. Arterburn, H. O. Smith, T. I. Oprea, L. A. Sklar, and H. J. Hathaway. 2008. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70: 165-190. (Pubitemid 351738176)
40. Wang, C., B. Dehghani, Y. Li, L. J. Kaler, T. Proctor, A. A. Vandenbark, and H. Offner. 2009. Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J. Immunol. 182: 3294-3303.
41. Otto, C., B. Rohde-Schulz, G. Schwarz, I. Fuchs, M. Klewer, D. Brittain, G. Langer, B. Bader, K. Prelle, R. Nubbemeyer, and K. H. Fritzemeier. 2008. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 149: 4846-4856.
42. Otto, C., I. Fuchs, G. Kauselmann, H. Kern, B. Zevnik, P. Andreasen, G. Schwarz, H. Altmann, M. Klewer, M. Schoor, et al. 2009. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol. Reprod. 80: 34-41.
43. Filardo, E. J., J. A. Quinn, A. R. Frackelton, Jr., and K. I. Bland. 2002. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 16: 70-84. (Pubitemid 34044499)
44. Wüst, S., J. Van den Brandt, D. Tischner, A. Kleiman, J. P. Tuckermann, R. Gold, F. Lühder, and H. M. Reichardt. 2008. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 180: 8434-8443.
45. Hermann-Kleiter, N., T. Gruber, C. Lutz-Nicoladoni, N. Thuille, F. Fresser, V. Labi, N. Schiefermeier, M. Warnecke, L. Huber, A. Villunger, et al. 2008. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 29: 205-216.
46. Klotz, L., S. Burgdorf, I. Dani, K. Saijo, J. Flossdorf, S. Hucke, J. Alferink, N. Nowak, M. Beyer, G. Mayer, et al. 2009. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. [Published erratum appears in 2009 J. Exp. Med. 206: 3159.] J. Exp. Med. 206: 2079-2089.
47. Glass, C. K., and K. Saijo. 2010. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nat. Rev. Immunol. 10: 365-376.